Clinical Trials Logo

Filter by:
NCT ID: NCT03772418 Recruiting - Clinical trials for Skin and Subcutaneous Tissue Disorders

Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities

Start date: May 18, 2018
Phase: Phase 1
Study type: Interventional

As the quality of life improves, people are seeking to look as young as they feel. Ginkgo biloba (GB) and Pomegranate (PG) extract can be used to create efficacious topical anti-aging products. GB & PG are now widely used in research and clinical trials on age-associated diseases, for example, skin aging, brain dysfunction, cardiovascular system diseases, carcinogen metabolism. The investigator's aim is to formulate a topical cream in the form (O/W or W/O emulsion) formulation, containing GB as an anti-aging formulation for the public.

NCT ID: NCT03772275 Recruiting - Heart Failure Clinical Trials

Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Clinical and Economic study of some new biomarkers in chronic heart failure.

NCT ID: NCT03770936 Recruiting - Liver Fibroses Clinical Trials

Effect of Some Drugs on Liver Fibrosis

Start date: October 1, 2018
Phase: Phase 3
Study type: Interventional

Effect of Some Drugs on Liver Fibrosis

NCT ID: NCT03770923 Recruiting - Clinical trials for Rheumatoid Arthritis

Effect of Some Drugs on Rheumatoid Arithritis Activity

Start date: October 1, 2018
Phase: Phase 3
Study type: Interventional

Effect of Some Drugs on Rheumatoid Arithritis Activity.

NCT ID: NCT03770702 Recruiting - Clinical trials for Rheumatoid Arthritis

Statins and ARBs on Rheumatoid Activity

Start date: October 1, 2018
Phase: Phase 3
Study type: Interventional

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

NCT ID: NCT03767283 Recruiting - Clinical trials for Antibiotic Resistant Strain

Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae

Start date: July 5, 2019
Phase:
Study type: Observational

Klebsiella pneumoniae is an important pathogen that frequently causes nosocomial community-acquired and infections, including pneumonia, urinary tract infections, bloodstream infections, pyogenic liver abscesses, and septic shock. An emerging co-existence of carbapenems and fluoroquinolone resistance in Klebsiella pneumoniae is causing major difficulty in treating infections caused by such pathogen

NCT ID: NCT03766451 Recruiting - Clinical trials for Intravascular Volume

Noninvasive Assessment of Intravascular Volume Status for Postoperative Patients

Start date: November 10, 2018
Phase:
Study type: Observational

Ultrasound measurements of the inferior vena cava (IVC) have been proposed as a noninvasive tool to help guide fluid management. Well-established correlations exist between respiratory cycle-induced changes in IVC diameter and C entral Venous Pressure (CVP) . Beyond providing an estimate of CVP, the caval index, or percentage collapsibility of the IVC , has been proposed as a predictor of preload reserve. This noninvasive rapid measurement of CVP is especially important in critical care settings. It can help in differentiating hypovolemic, septic and cardiogenic shock. Changes in volume status will be depicted by change in the diameter of the IVC . However, the validity and reliability of sonographic assessment of the inferior vena cava have been matters of controversy, and its applicability has been shown to be limited by technical difficulties. Recent study has shown a significant relationship between the internal jugular vein/common carotid artery (IJV/CCA) cross-sectional area ratio and CVP in pediatric burn patients .

NCT ID: NCT03763201 Recruiting - Clinical trials for Rheumatoid Arthritis

Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis

GITR
Start date: November 8, 2018
Phase:
Study type: Observational

This study aimed to measure serum and synovial fluid (SF) levels of GITR in patients with recent onset RA before and after initiation of therapy

NCT ID: NCT03762785 Recruiting - Abdominal Cancer Clinical Trials

Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine

Start date: December 10, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

the aim of this study is to study the pharmacokinetics and dynamics of nebulized dexmetedomidine in children undergoing major abdominal cancer surgery.

NCT ID: NCT03758144 Recruiting - Type2 Diabetes Clinical Trials

Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Gut Dysbiosis had been involved in some way in the pathogenesis of some extra-intestinal disorders including metabolic syndrome, cardiovascular disease, and obesity.